Benitec Biopharma Target Price

See Benitec Biopharma's analyst price targets ($16) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$9.28

Average Target Price

$15.67

68.8% upside

3 analysts in the last 4 months

High: $17 | Low: $14

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-10-23	Raymond JamesTiago Fauth	$14	50.9% upside
2026-09-15	Wedbush	$17	83.2% upside
2026-07-28	Wedbush	$16	72.4% upside
2026-05-12	Evercore ISI	$25	169.4% upside
2025-11-24	H.C. WainwrightRaghuram Selvaraju	$32	244.8% upside
2025-11-04	H.C. Wainwright	$35	277.2% upside
2025-11-04	JMP Securities	$22	137.1% upside
2025-09-16	OppenheimerAndreas Argyrides	$29	212.5% upside
2024-10-14	JMP SecuritiesSilvan Tuerkcan	$18	94% upside
2024-10-14	JMP SecuritiesSilvan Tuerkcan	$16	72.4% upside
2024-10-14	Leerink PartnersMani Foroohar	$13	40.1% upside
2024-09-24	Piper SandlerYasmeen Rahimi	$30	223.3% upside

Benitec Biopharma (BNTC) FAQ

Benitec Biopharma posts a target price of $16. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $16 for BNTC means covering analysts, on average, see the stock 68.8% upside of $9.28 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for BNTC's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Benitec Biopharma's other metric pages and overview cover the third.